Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
Large-scale serological testing in the population is essential to determine the true extent of the current SARS-CoV-2 pandemic. Serological tests measure antibody responses against pathogens and use predefined cutoff levels that dichotomize the quantitative test measures into sero-positives and nega...
Main Authors: | Judith A Bouman, Julien Riou, Sebastian Bonhoeffer, Roland R Regoes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-02-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1008728 |
Similar Items
-
Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva
by: Judith A. Bouman, et al.
Published: (2022-06-01) -
Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01) -
Evolution of parasite transmission dispersion
by: Hannelore MacDonald, et al.
Published: (2025-01-01) -
COVID-19 infectivity profile correction
by: Peter Ashcroft, et al.
Published: (2020-08-01) -
Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)